Yongtaipharmaceutical Co., Ltd was established

Metoprolol tartrate DMF submitted to FDA

In November 2016, Nevirapine API underwent domestic on-site Inspection and obtained a GMP certificate In December 2016, the pharmacy opened

CEP certificate of duloxetine hydrochloride in April 2017. In August 2017, metoprolol tartrate was FDA approved.

Rosuvastatin and doxycycline hydrochloride capsules Anda were submitted to the FDA in May and September 2018 In October 2018, Nevirapine dispersible tablets passed the domestic GMP certification. In October 2018, Rosuvastatin passed FDA on site inspections.

Doxycycline Hydrochloride capsules pass FDA inspection in March 2019.

In August 2020, Gabapentin capsules passed FDA inspection.